Lo Andrew
CIK 0001679076
Director
Filings
9
Latest Nov 19, 2025
Issuers covered
2
Showing
9 of 9
Page 1
Track record
7 of 7 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 7 | 14% | -15.4% | -13.0% | +8.1% | -36.3% |
| 90 days | 7 | 0% | -19.0% | -15.6% | -13.4% | -28.7% |
| 180 days | 7 | 57% | -20.2% | +0.4% | +2.4% | -72.7% |
| 365 days | 3 | 0% | -57.7% | -47.6% | -46.7% | -78.9% |
Issuers
Companies where Lo Andrew has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| BBIO | Bridgebio Pharma, Inc. | 7 | Nov 19, 2025 |
| ABCL | Abcellera Biologics Inc. | 2 | Jun 16, 2025 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|